Vontobel Holding Ltd. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 259 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
Vontobel Holding Ltd. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$222,147
+5.3%
5,477
-10.3%
0.00%0.0%
Q2 2022$211,000
-24.1%
6,1040.0%0.00%0.0%
Q1 2022$278,000
-38.2%
6,104
-8.6%
0.00%
-50.0%
Q4 2021$450,000
-40.6%
6,678
-45.0%
0.00%
-42.9%
Q3 2021$758,000
-0.3%
12,144
+32.4%
0.01%0.0%
Q2 2021$760,000
+7.0%
9,173
-14.3%
0.01%
+40.0%
Q1 2021$710,000
-40.6%
10,700
-31.4%
0.01%
+25.0%
Q4 2020$1,196,00015,6000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 1,909,330$3,532,0000.77%
QVT Financial LP 2,556,256$4,729,0000.15%
Fiera Capital (Europe) Ltd. 102,815$193,0000.09%
Perceptive Advisors 847,458$1,567,0000.09%
TFS CAPITAL LLC 49,901$92,0000.03%
A.R.T. Advisors, LLC 229,590$424,0000.02%
AGRAN LIBBIE 20,600$38,0000.01%
TUDOR INVESTMENT CORP ET AL 139,900$259,0000.01%
OppenheimerFunds, Inc. 3,000,000$5,550,0000.01%
Edge Wealth Management LLC 10,000$19,0000.01%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders